Subscribe to Newsletter
Business & Regulation Standards & Regulation

Medicare Reveals Coverage Policy for Amyloid mAbs

| Stephanie Vine

Medicare publishes policy for amyloid mAbs and Alzheimer’s disease. It’s not good news for Aduhelm.

Business & Regulation Digital Technologies

And the Supreme Innovator Is…

| Angus Stewart

Get excited, because the results are in! Find out who won the 2022 Innovation Awards

Business & Regulation COVID-19

A Tale of Two Continents

| Angus Stewart

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

Business & Regulation Business Practice

Speaking the Language of Pharmaceutical Success

| Maryam Mahdi

We sat down to talk shop with Novo Nordisk Executive Vice President Ludovic Helfgott

Business & Regulation Biosimilars

Brace for Biosimilars!

| Jeff Baldetti

One decade behind the EU, biosimilars are arriving in the US. What can we expect? Jeff Baldetti from Cardinal Health has a few ideas.

Business & Regulation Standards & Regulation

Sharing is Caring (for Animals)

| Stephanie Vine

How an initiative from EFPIA and a new public database on chemical substances could reduce animal experiments.

Manufacture Vaccines

Taking the mRNA Highway from Development to Commercialization

| Serena Fries Smith

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Manufacture Supply Chain

Supply Chains: Real-world Problems, Digital Solutions

| Maryam Mahdi

Overcoming supply chain woes will require digital intervention.

Discovery & Development Drug Discovery

Neurons: In the Know

| Jim Ross

How bioelectronic assays helped demonstrate the value of 3D iPSC cultures in modeling human brain development.

Business & Regulation Business Practice

Done Deal: Creating Anti-COVID-19 Equity

| Maryam Mahdi

Medicines Patent Pool has joined forces with over 30 generic manufacturers to help ensure access to anti-COVID-19 medicines for all.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register